A new survey suggests that medical marijuana is gaining acceptance among doctors who treat malignant mesotheliomaand other types of cancer, opening the door for more patients to explore its potential to manage their disease.
The survey of 400 oncologists conducted by the American Society of Clinical Oncology found that as many as 80 percent of the 237 respondents have discussed medical marijuana with their patients. The survey found this was usually because a patient brought it up.
Unfortunately for mesothelioma patients, the survey also revealed that fewer than one in three doctors felt knowledgeable enough about medical marijuana to make a recommendation.
“We need to bridge this gap so oncologists have the unbiased information they need to assist with decision-making related to medical marijuana use,” said study author Ilana Braun, MD, of the Dana-Farber Cancer Institute in a news release.
Key Findings from Marijuana Doctor Survey
The good news to come out of the survey for people facing a mesothelioma diagnosis is that, if they are interested in integrating medical marijuana into their treatment, they are more likely to find that their doctor is open to the idea, especially if they live in a Western state where medical marijuana is legal.
Nearly half (46%) of the survey respondents say they had recommended medical marijuana to cancer patients within the past year.